AlphaGrep UK
GH icon

AlphaGrep UK’s Guardant Health GH Stock Holding History

AlphaGrep UK’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$208K Sell
1,167
-949
-45% -$155K 0.06% 667
2026
Q2 		$317K Sell
2,116
-684
-24% -$74.4K 0.09% 440
2026
Q1 		$259K Buy
2,800
+693
+33% +$69.6K 0.07% 584
2025
Q4 		$215K Buy
+2,107
New +$188K 0.07% 598

Other funds holding GH

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Franklin Resources
Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $483B AUM 27.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $71.4B AUM 33.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

AlphaGrep UK's GH Position: Q3 2026 in Review

AlphaGrep UK reduced its Guardant Health (GH) stake by 45% in Q3 2026, selling an estimated $155K and leaving 1,167 shares worth $208K. The position accounts for 0.06% of the portfolio, ranked #667.

AlphaGrep UK first reported a position in GH in Q4 2025 and has held it in 4 quarters since. The position peaked at $317K in Q2 2026. 511 funds tracked by Wall St. Rank hold GH as of Q3 2026.

  • AlphaGrep UK held 1,167 shares of Guardant Health worth $208K as of Q3 2026.
  • AlphaGrep UK sold 949 Guardant Health shares in Q3 2026, an estimated $155K.
  • Guardant Health made up 0.06% of AlphaGrep UK's portfolio in Q3 2026, its #667 holding.
  • AlphaGrep UK first reported a position in Guardant Health in Q4 2025 and has held it in 4 quarters since.
  • AlphaGrep UK's Guardant Health position peaked at $317K in Q2 2026.
  • 511 funds tracked by Wall St. Rank held Guardant Health as of Q3 2026.

Based on AlphaGrep UK's 13F filing for Q3 2026, filed 12 Nov 2026.